SMTL ID : 2w0u.2 (3 other biounits)

CRYSTAL STRUCTURE OF HUMAN GLYCOLATE OXIDASE IN COMPLEX WITH THE INHIBITOR 5-[(4-CHLOROPHENYL)SULFANYL]- 1,2,3-THIADIAZOLE-4-CARBOXYLATE.

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.84 Å

Oligo State

homo-tetramer

Ligands

4 x C7C: 5-[(4-chlorophenyl)sulfanyl]-1,2,3-thiadiazole-4-carboxylate(Non-covalent)

C7C.1: 11 residues within 4Å: Chain A: Y.26, M.82, W.110, Y.132, R.167, L.205, Y.208, V.209, H.260, R.263 Ligands: FMN.2 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:W.110, A:V.209 Hydrogen bonds: A:Y.26, A:Y.26 Salt bridges: A:R.167, A:H.260, A:R.263 pi-Stacking: A:W.110, A:W.110 C7C.3: 11 residues within 4Å: Chain B: Y.26, M.82, W.110, Y.132, R.167, L.205, Y.208, V.209, H.260, R.263 Ligands: FMN.4 9 PLIP interactions: 9 interactions with chain B Hydrophobic interactions: B:W.110, B:V.209 Hydrogen bonds: B:Y.26, B:Y.26 Salt bridges: B:R.167, B:H.260, B:R.263 pi-Stacking: B:W.110, B:W.110 C7C.5: 11 residues within 4Å: Chain C: Y.26, M.82, W.110, Y.132, R.167, L.205, Y.208, V.209, H.260, R.263 Ligands: FMN.6 9 PLIP interactions: 9 interactions with chain C Hydrophobic interactions: C:W.110, C:V.209 Hydrogen bonds: C:Y.26, C:Y.26 Salt bridges: C:R.167, C:H.260, C:R.263 pi-Stacking: C:W.110, C:W.110 C7C.7: 11 residues within 4Å: Chain D: Y.26, M.82, W.110, Y.132, R.167, L.205, Y.208, V.209, H.260, R.263 Ligands: FMN.8 9 PLIP interactions: 9 interactions with chain D Hydrophobic interactions: D:W.110, D:V.209 Hydrogen bonds: D:Y.26, D:Y.26 Salt bridges: D:R.167, D:H.260, D:R.263 pi-Stacking: D:W.110, D:W.110

4 x FMN: FLAVIN MONONUCLEOTIDE(Non-covalent)

FMN.2: 23 residues within 4Å: Chain A: Y.26, Y.27, A.79, T.80, A.81, S.108, S.109, Q.130, Y.132, T.158, K.236, S.258, H.260, G.261, R.263, D.291, G.292, G.293, R.295, V.313, G.314, R.315 Ligands: C7C.1 18 PLIP interactions: 18 interactions with chain A Hydrophobic interactions: A:Y.26, A:Y.27, A:T.80, A:R.315 Hydrogen bonds: A:A.79, A:A.79, A:A.81, A:S.109, A:K.236, A:K.236, A:S.258, A:G.261, A:G.292, A:G.293, A:G.314, A:R.315 Salt bridges: A:R.295, A:R.315 FMN.4: 23 residues within 4Å: Chain B: Y.26, Y.27, A.79, T.80, A.81, S.108, S.109, Q.130, Y.132, T.158, K.236, S.258, H.260, G.261, R.263, D.291, G.292, G.293, R.295, V.313, G.314, R.315 Ligands: C7C.3 18 PLIP interactions: 18 interactions with chain B Hydrophobic interactions: B:Y.26, B:Y.27, B:T.80, B:R.315 Hydrogen bonds: B:A.79, B:A.79, B:A.81, B:S.109, B:K.236, B:K.236, B:S.258, B:G.261, B:G.292, B:G.293, B:G.314, B:R.315 Salt bridges: B:R.295, B:R.315 FMN.6: 23 residues within 4Å: Chain C: Y.26, Y.27, A.79, T.80, A.81, S.108, S.109, Q.130, Y.132, T.158, K.236, S.258, H.260, G.261, R.263, D.291, G.292, G.293, R.295, V.313, G.314, R.315 Ligands: C7C.5 18 PLIP interactions: 18 interactions with chain C Hydrophobic interactions: C:Y.26, C:Y.27, C:T.80, C:R.315 Hydrogen bonds: C:A.79, C:A.79, C:A.81, C:S.109, C:K.236, C:K.236, C:S.258, C:G.261, C:G.292, C:G.293, C:G.314, C:R.315 Salt bridges: C:R.295, C:R.315 FMN.8: 23 residues within 4Å: Chain D: Y.26, Y.27, A.79, T.80, A.81, S.108, S.109, Q.130, Y.132, T.158, K.236, S.258, H.260, G.261, R.263, D.291, G.292, G.293, R.295, V.313, G.314, R.315 Ligands: C7C.7 18 PLIP interactions: 18 interactions with chain D Hydrophobic interactions: D:Y.26, D:Y.27, D:T.80, D:R.315 Hydrogen bonds: D:A.79, D:A.79, D:A.81, D:S.109, D:K.236, D:K.236, D:S.258, D:G.261, D:G.292, D:G.293, D:G.314, D:R.315 Salt bridges: D:R.295, D:R.315

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bourhis, J.M. et al., Structure of Human Glycolate Oxidase in Complex with the Inhibitor 4-Carboxy-5-[(4-Chlorophenyl)Sulfanyl]-1,2,3-Thiadiazole. Acta Crystallogr.,Sect.F (2009)

Release Date

2009-11-10

Peptides

HYDROXYACID OXIDASE 1: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

B
B

C
B

D
B

HYDROXYACID OXIDASE 1

Related Entries With Identical Sequence